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Lipolytic activityA wide spectrum of commercially available lipases and microbial whole cells catalysts were tested for
biotransformations of 2-hydroxy-2-(ethoxyphenylphosphinyl)acetic acid 1 and its butyryl ester. The best
results were achieved for biocatalytic hydrolysis of ester: 2-butyryloxy-2-(ethoxyphenylphosphinyl)ace
tic acid 2 performed by lipase from Candida cylindracea, what gave optically active products with 85%
enantiomeric excess, 50% conversion degree and enantioselectivity 32.9 for one pair of enantiomers.
Also enzymatic systems of Penicillium minioluteum and Fusarium oxysporumwere able to hydrolyze tested
compound with high enantiomeric excess (68–93% ee), enantioselectivity (44 for one pair of enan-
tiomers) and conversion degree about 50–55%. Enzymatic acylation of hydroxyphosphinate was success-
ful in case when porcine pancreas lipase was used. After 4 days of biotransformation the conversion
reaches 45% but the enantiomeric enrichment of the isomers mixture do not exceed 43%. Obtained chiral
compounds are valuable derivatizing agents for spectroscopic (NMR) evaluation of enantiomeric excess
for particular compounds (e.g. amino acids).
 2016 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Chirality is a key factor for the activity and properties of many
compounds produced for pharmaceutical, fine chemicals and
agroalimentary industries, so the production of single enantiomer
is increasingly in demand. Obtaining enantiopure active com-
pounds with a defined configuration for pharmaceutical purposes
become more desirable, because of effectiveness of such products
and strict safety, quality and environmentally requirements of
industrial synthetic processes. Single enantiomers can be obtained
via chemical or chemoenzymatic synthesis [1,2]. Biocatalysis is
defines as green technology useful for the synthesis of chiral mole-
cules due to enormous potential of microorganisms and enzymes
for the transformation of nonphysiological substrates with high
chemo-, regio- and enantioselectivity in water under mild condi-
tions [3,4]. Biotransformation is often applied to resolve racemic
mixtures of chiral starting material or to create one or more chiral
centers in the final compound [5].
Hydrolases, more particularly lipases, due to their wide toler-
ance towards synthetic substrates, low substrate specificity and
high stereoselectivity of catalyzed reactions, are the mostcommonly used enzymes involved in enantioselective biotransfor-
mations [6]. Moreover, many of them are commercially available
and easy to handle. Lipases are employed in hydrolysis of esters
and amides, they also catalyze esterification and transesterification
of secondary alcohols and amines. Effectiveness of the reactions
depend on the process conditions e.g. reaction medium – biocon-
versions are carried out in aqueous medium (hydrolysis), organic
solvents (esterification and transesterification), ionic liquids and
non-conventional solvents allowing for the transformations of
non-water soluble compounds [2,7–9]. Lipolytic enzymes are used
for the synthesis of chiral molecules, via the kinetic resolution of
racemic mixtures and the enantioselective enzymatic desym-
metrization of prochiral compounds [2,10,11].
Chiral hydroxyphosphonates, due to structural similarity to bio-
logically important phosphates and due to the structural analogy
between a-hydroxyalkylphosphonic and a-hydroxycarboxylic
acids, exhibit various biological activities, what allow applying
them as antibacterial, antiviral and antitumour agents, antibiotics,
enzyme inhibitors, amino acid mimetics and pesticides [12]. That is
why they appeared to be the synthetic platform for many
applications.
As the biological activity of phosphonic acids is markedly influ-
enced by the absolute configuration of the stereogenic a-carbon
atom, the synthesis of optically pure enantiomers of phosphonic
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important task in organic synthesis. The strategy for this challeng-
ing transformation of chiral a-hydroxyalkylphosphonic acids mostly
relies upon kinetic resolution, chemoenzymatic synthesis and asym-
metric synthesis. Hydroxyalkylphosphonates can be obtained by
enzymatic method such as: (a) bioreduction of ketophosphonates;
(b) enantioselective acylation of hydroxyphosphonates; (c) hydro-
lysis of acyloxyalkanephosphonates; (d) hydrolytic oxirane ring
opening in substituted 1,2-epoxyethanephosphonates [12,13].
The aim of this study was to resolve the racemic mixture of chi-
ral 2-hydroxy-2-(ethoxyphenylphosphinyl)acetic acid (compound
with two stereogenic centers) 1 (Fig. 1) by bioconversion. Two dif-
ferent strategies were examined - hydrolysis of the ester: 2-butyr
yloxy-2-(ethoxyphenylphosphinyl)acetic acid 2 (Fig. 2) and esteri-
fication of 2-hydroxy-2-(ethoxyphenylphosphinyl)acetic acid 1
(Fig. 3) using microorganisms and lipases of different origin. Enan-
tiomers of this compound are valuable because, among others,
they could be convenient chiral auxiliaries, useful in 31P NMR spec-
troscopy for the determination of the enantiomeric purity and
absolute configuration of various classes of compounds. Optically
pure products can also find application as building blocks of
defined absolute configuration in synthesis of biologically active
compounds such as pharmaceuticals or pesticides.2. Materials and methods
All materials were purchased from Sigma Aldrich (St. Louis,
Missouri, United States), POCh (Gliwice, Poland) or BIOCORP
(Warszawa, Poland) and were used without further purification.
NMR spectra were performed on a Bruker AvanceTM 600 at
600.58 MHz for 1H; 243.12 MHz for 31P and 151.02 MHz for 13C
in CDCl3 (99.8% of atom D, contains 0.03% v/v TMS) or on a Bruker
AvanceTM DRX 300 instrument operating at 300.13 MHz for 1H;
121.50 MHz for 31P and 75.45 MHz for 13C in CDCl3 (99.8% of atom
D, contains 0.03% v/v TMS). Chemical shifts (d) are reported in ppm.Fig. 1. 31P NMR spectrum of products of hydrolysis of 2-butyryloxy-2-(eThe biotransformations products were analyzed by 31P NMR. In the
case where not all the signals of the enantiomers have been separated,
the sample was added quinine as a Chiral Solvating Agent (CSA).
2.1. Synthesis of phosphonic derivatives - bio transformations
substrates
Compounds 1 and 2 (Fig. 1) were synthesized according to the
method described by Majewska [14].
2.1.1. Synthesis of 2-hydroxy-2-(ethoxyphenylphosphinyl)acetic acid 1
(Fig. 1)
The amount of 3.40 g (20 mmol) of ethyl phenylphosphinate
was mixed with 1.84 g (20 mmol) of glyoxylic acid monohydrate
and 2.79 mL (20 mmol) triethylamine. The resulting solution was
stirred for 2 h at room temperature. Thereafter, the reaction mix-
ture was dissolved in 10 mL of distilled water and triethylamine
was removed from the solution by ion exchange chromatography
(Dowex 50W X8 50–100 mesh). After purification, 3.39 g (69.5%
yield) of pure 2-hydroxy-2-(ethoxyphenylphosphinyl)acetic acid
1 (Fig. 1), was obtained. MS (TOF MS ES+) Calcd for C10H13O5P
[M]+ 245.0579; found: 245.0588; Calcd for C10H13O5PNa [M+Na]+
267.0398; found: 267.0448.
(RP,S), (SP,R).
1H NMR (CDCl3, d, ppm): 1.28 (t, J = 7.1 Hz, 3H, POCH2CH3),
4.07–4.25 (m, 2H, POCH2CH3), 4.73 (d, J = 10.9 Hz, 1H, PCH),
7.42–7.85 (m, 5H, PC6H5).
31P NMR (CDCl3, d, ppm): 35.41.
13C NMR (CDCl3, d, ppm): 16.41 (d, J = 5.7 Hz, 1C, POCH2CH3),
63.31 (d, J = 6.9 Hz, 1C, POCH2CH3), 71.01 (d, J = 105.2 Hz, 1C,
PCH), 127.19 (d, J = 134.1 Hz, 1C, PC6H5), 128.59 (d, J = 13.2 Hz,
2C, PC6H5), 132.65 (d, J = 9.9 Hz, 2C, PC6H5), 133.28 (1C, PC6H5),
170.73 (1C, COOH).
(RP,R), (SP,S).thoxyphenylphosphinyl)acetic acid 2 by Candida cylindracea lipase.
Fig. 2. Hydrolysis of 2-butyryloxy-2-(ethoxyphenylphosphinyl)acetic acid 2.
Fig. 3. Esterification of 2-hydroxy-2-(ethoxyphenylphosphinyl)acetic acid 1.
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4.07–4.25 (m, 2H, POCH2CH3), 4.78 (d, J = 13.1 Hz, 1H, PCH),
7.42–7.85 (m, 5H, PC6H5).
31P NMR (CDCl3, d, ppm): 36.42.
13C NMR (CDCl3, d, ppm): 16.41 (d, J = 5.7 Hz, 1C, POCH2CH3),
63.12 (d, J = 7.1 Hz, 1C, POCH2CH3), 70.54 (d, J = 106.5 Hz, 1C,
PCH), 126.87 (d, J = 134.1 Hz, 1C, PC6H5), 128.62 (d, J = 13.3 Hz,
2C, PC6H5), 132.54 (d, J = 9.9 Hz, 2C, PC6H5), 133.28 (1C, PC6H5),
170.80 (1C, COOH).2.1.2. Synthesis of 2-butyryloxy-2-(ethoxyphenylphosphinyl)acetic
acid 2 (Fig. 1)
The amount of 3.40 g (20 mmol) of ethyl phenylphosphinate
was mixed with 1.84 g (20 mmol) of glyoxylic acid monohydrate
and 2.79 mL (20 mmol) triethylamine. The resulting solution was
stirred for 2 h at room temperature. Thereafter, the reaction mix-
ture was dissolved in 100 mL of chloroform, placed in an ice bath
and 2.07 mL (20 mmol) of butyryl chloride was slowly added drop-
wise. After completion of the reaction, which lasted for two days as
monitored by TLC, the resulting solution was extracted with
100 mL of distilled water, the organic phase was dried by magne-
sium sulfate anhydrous, evaporated and the product was purified
by column chromatography (Merck Silica Gel 60; 63–230 mesh)
using dichloromethane: isopropanol at a ratio of 100:5 as eluent.
After purification, 3.89 g (61.9% yield) of pure 2-butyryloxy-2-(et
hoxyphenylphosphinyl)acetic acid 2 (Fig. 1) was obtained. MS
(TOF MS ES+) Calcd for C14H19O6P [M+H]+ 315.0998; found:
315.0988; Calcd for C14H19O6PNa [M+Na]+ 337.0817; found:
337.0982.
(RP,S), (SP,R).
1H NMR (CDCl3, d, ppm): 0.90 (t, J = 7.4 Hz, 3H, CH2CH2CH3),
1.37 (t, J = 7.0 Hz, 3H, POCH2CH3), 1.56–1.67 (m, 2H, CH2CH2CH3),
2.31–2.46 (m, 2H, CH2CH2CH3), 4.22–4.38 (m, 2H, POCH2CH3),
5.63 (d, J = 10.4 Hz, 1H, PCH), 7.48–7.91 (m, 5H, PC6H5).
31P NMR (CDCl3, d, ppm): 33.21.
13C NMR (CDCl3, d, ppm): 13.40 (1C, CH2CH2CH3), 16.38 (d,
J = 5.3 Hz, 1C, POCH2CH3), 18.15 (1C, CH2CH2CH3), 35.50 (1C,
CH2CH2CH3), 63.52 (d, J = 6.1 Hz, 1C, POCH2CH3), 70.29 (d,
J = 106.6 Hz, 1C, PCH), 127.16 (d, J = 142.0 Hz, 1C, PC6H5), 128.65(d, J = 13.5 Hz, 2C, PC6H5), 132.45 (d, J = 9.8 Hz, 2C, PC6H5), 133.46
(1C, PC6H5), 166.08 (1C, COCH2CH2CH3), 171.69 (1C, COOH).
(RP,R), (SP,S).
1H NMR (CDCl3, d, ppm): 0.79 (t, J = 7.4 Hz, 3H, CH2CH2CH3),
1.37 (t, J = 7.0 Hz, 3H, POCH2CH3), 1.40–1.51 (m, 2H, CH2CH2CH3),
2.11–2.29 (m, 2H, CH2CH2CH3), 4.17–4.41 (m, 2H, POCH2CH3),
5.79 (d, J = 13.6 Hz, 1H, PCH), 7.48–7.91 (m, 5H, PC6H5).
31P NMR (CDCl3, d, ppm): 35.19.
13C NMR (CDCl3, d, ppm): 13.47 (1C, CH2CH2CH3), 16.38 (d,
J = 5.3 Hz, 1C, POCH2CH3), 18.06 (1C, CH2CH2CH3), 35.46 (1C, CH2-
CH2CH3), 63.52 (d, J = 6.1 Hz, 1C, POCH2CH3), 69.96 (d,
J = 109.9 Hz, 1C, PCH), 126.76 (d, J = 141.4 Hz, 1C, PC6H5), 128.62
(d, J = 13.5 Hz, 2C, PC6H5), 132.45 (d, J = 9.8 Hz, 2C, PC6H5), 133.46
(1C, PC6H5), 165.83 (1C, COCH2CH2CH3), 171.81 (1C, COOH).
2.2. Microorganisms: growth conditions and whole cell
biotransformation procedure
Fungal strains were generous gift from following institutions:
Aspergillus niger, Penicillium citrinum – Opole University (Poland);
Aspergillus fumigatus – University of Pavia (Italy); Beauveria bassi-
ana (2715B) – Polish Academy of Science (Poland); Mucor circinel-
loides – Lodz University of Technology (Poland); Fusarium
culmorum – Wroclaw University (Poland); Penicillium sp. (ATCC
20170) – Andolu University (Turkey). Penicillium purpurogenum
(S1), Penicillium crustosum (S2), Penicillium funiculosum (S3) were
isolated and identified by Klimek-Ochab [15]. Fusarium oxysporum
(DSM 12646), Geotrichum candidum, Rhodotorula glutinis, Rhodotor-
ula gracilis, Rhodotorula mucilaginosa, Penicillium minioluteum, Rho-
dosporidium toruloides (DMS 4444), Trigonopsis variabilis (DSM
70714) were purchased from German Collection of Microorgan-
isms and Cell Cultures (Germany).
2.2.1. Conditions of microorganism cultivation
2.2.1.1. Method A. Microorganisms were stored on a Lab Chloram-
phenicol Agar (Difco) supplemented with 1% of olive oil and then
transferred into the medium defined as growth and the lipolytic
activity stimulating one (H1). It consist of (1 L) 30 g of yeast
extract, 1 g of KH2PO4, 1 g of NaNO3, 0.5 g of MgSO4, 10 mL of olive
oil, pH was set at 7.0. Medium H1 was inoculated with 500 lL of
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was agitated (130 rpm) and maintained at room temperature until
the beginning of logarithmic phase of growth was reached. Accord-
ingly to the growth duration for P. citrinum was defined as four
days and for other Penicillium sp. and for F. culmorum as five days.
After cultivation biomass was separated by filtration, rinsed with
distilled water and then was ready to use for bioconversion.2.2.1.2. Method B. Microorganisms stored on a potato dextrose agar
(BIOCORP) were used for inoculation of PDB medium. Selected
strains were cultivated in 250 mL Erlenmeyer flask containing
100 mL of potato dextrose broth (PDB) for 3 days at room temper-
ature with shaking (135 rpm). Then the biomass was separated by
filtration and rinsed with distilled water to remove medium resid-
ual. In the case of F. oxysporum and P. minioluteum biocatalyst cells
were separated by centrifugation and then washed with water.2.2.2. Biotransformation procedure. Microbial hydrolysis of
compound2
Particular biocatalysts cells were suspended in 50 mL of dis-
tilled water containing 50 mg (0.16 mmol) of substrate dissolved
in 0.5 mL of acetone. Bioconversions were carried out for 3 days
(for Penicillium sp. and F. culmorum- for 5 days) at room tempera-
ture with shaking (135 rpm). After that, biomass was removed by
filtration or centrifugation, and supernatants were evaporated
under reduced pressure using rotary evaporator. The resulting pre-
cipitates were extracted with acetonitrile. Solid residues were
removed by filtration, the solvent was evaporated and the residues
were dissolved in 5 mL of distilled water. Obtained solutions were
purified by ion exchange chromatography on column filled with
Dowex (200–400 mesh) with the use of water as eluent. Then
evaporated fractions were analyzed by 31P NMR with the addition
of quinine as a chiral discriminating agent.2.3. Enzymes: enzymatic catalysis conditions
CCL – Candida cylindracea lipase; CAL – Candida antarctica
lipase; NZ-435 – Novozyme 435; MCL – Mucor circinelloides lipase;
BCL – Burkholderia cepacia lipase; ROL – Rhizopus oryzae lipase; MJL
–Mucor javanicus lipase; PCL – Penicillium camemberti lipase; CRL –
Candida rugose lipase; PPL – porcine pancreas lipase.2.3.1. Procedure of enzymatic hydrolysis of 2
Enzymatic hydrolysis reactions were carried out in a biphasic
system (3.8 mL) consisting of 0.05 M phosphate buffer, pH 7.0
(3.0 mL) and a mixture of di-isopropyl ether (0.2 mL) with n-
hexane (0.6 mL). After addition of 0.2 mmol of substrate and
100 mg of a suitable lipase, reactions were carried out at room
temperature with shaking (150 rpm) and stopped after certain
periods of time by the addition of 2 mL of acetone and the filtration
of precipitated protein. Liquid fraction - solvent was removed by
evaporation. The resulting products were analyzed by 31P NMR.2.3.2. Procedure of enzymatic esterification of 1
Enzymatic acylation reactions were carried out in di-
isopropylether (2 mL) with the addition of 20 mg of powdered
molecular sieves (3 Å mesh). The amount of 0.02 mmol of the sub-
strate, and 200 mg of a suitable lipase and 0.165 mmol of vinyl n-
butyrate were added. Reactions were carried out at 36 C with
shaking (150 rpm) and stopped after certain periods of time by fil-
tration followed by evaporation of the organic layer. The conver-
sion degree and enantiomeric excess of the obtained products
were analyzed by analytical HPLC with chiral column Chiralpack
AD.3. Results and discussion
For the synthesis of optically pure, desired phosphinate deriva-
tives two approaches were applied. Hydrolysis of racemic mixture
of ester: 2-butyryloxy-2-(ethoxyphenylphosphinyl)acetic acid 2
(Fig. 1) by microorganisms and lipolytic enzymes was the first
method whereas the second approach was based upon the enzy-
matic acylation of 2-hydroxy-2-(ethoxyphenylphosphinyl)acetic
acid 1 (Fig. 1) by vinyl butyrate.3.1. Resolution of stereoisomers
First attempts for resolution of diastereoisomers of 2-hydroxy-
2-(ethoxyphenylphosphinyl)acetic acid 1 and 2-butyryloxy-2-(eth
oxyphenylphosphinyl)acetic acid 2 were described in previous
work [14]. Few more experiments were carried out for obtaining
pure pair of enantiomers 2-butyryloxy-2-(ethoxyphenylphosphi
nyl)acetic acid 2 using column chromatography by the application
of various eluents or by application of medium-pressure chro-
matography system. Unfortunately, they appeared to be unsuc-
cessful. When silica gel column and mixture of ethyl acetate/n-
hexane/2-propanol (5:4:1 v/v) as eluent was used some enrich-
ment of the isomers of compound 2 was obtained. In one of the
fractions small amount of compound 2 with a molar ratio of
diastereomers 1:0.15 was found. Similar results were achieved
when attempts were made to separate the diastereomers of com-
pound 2 using the medium-pressure chromatography system with
reverse-phase column in gradient of water and acetonitrile (5 min
of pure water, 5 min from pure water to 5% of acetonitrile in water,
5 min of isocratic flow, 5 min from 5% to 10% of acetonitrile in
water, 5 min of isocratic flow, 5 min from 10% to 15% of acetonitrile
in water followed by a 75 min of isocratic flow, increasing gradient
to 100% of acetonitrile for 10 min, then maintained for 5 min). The
identified retention time was extended, and the signal from com-
pound 2 appeared between 45 and 120 min. Subsequent fractions
were collected into separate tubes and in one of them small
amount (38 mg from 500 mg injection) of compound 2 with a
molar ratio of diastereomers 1:0.1 was found. The content of few
next tubes was mixed giving a molar ratio of diastereomers 1:0.8.3.2. Enzymatic hydrolysis of substrate 2
Application of lipase from C. cylindracea allowed hydrolyzing
compound 2 with good conversion degree (48–50%) and enantios-
electivity (73–85%) (Fig. 1). Other biocatalysts applied were less
effective – enantiomeric excesses were lower than expected when
lipases from Candida rugosa (14–57%) and B. cepacia (10–37%) were
employed. M. javanicus lipase and R. oryzae lipase hydrolyze tested
compound 2with average conversion degree (respectively 24% and
36%) but low enantioselectivity (less than 5%). Other lipases: por-
cine pancreas lipase, P. camemberti lipase, Novozyme 435 and M.
circinelloides lipase were not active towards compound 2 – the con-
version was lower than 20% and enantiomeric excess not higher
than 5%. In every case the SP preference in stereoselectivity of bio-
catalysts was observed (Table 1, Fig. 2). The best result is bolded in
Table 1.3.3. Enzymatic acylation of 1
In this case, because of the low substrate and product concen-
trations enantiomeric excess was verified not by the means of
NMR spectroscopy but by HPLC with the chiral support packed col-
umn. However, this method turned out to be too little precise to
distinguish every stereoisomer in the mixture of two stereogenic
Table 1
Enzymatic hydrolysis of ester: 2-butyryloxy-2-(ethoxyphenylphosphinyl)acetic acid 2 in biphasic system (0.2 mmol of substrate, 100 mg of lipase).
Enzyme Time [days] Conversion [%] ee of product [%] ee of substrate [%] E
(SP,S); (RP,R) (SP,R); (RP,S) (SP,S) (SP,R) (RP,R) (RP,S) (SP,S) (SP,R)
CCL 4 48 50 85 73 84 85 32.9 16.8
CRL 7 51 43 57 37 21 14 4.5 2.5
BCL 7 26 20 37 10 10 18 2.4 1.4
MJL 7 24 21 <5 <5 <5 <5 – –
ROL 7 36 35 <5 <5 <5 <5 – –
Table 2
Microbial hydrolysis of 2-butyryloxy-2-(ethoxyphenylphosphinyl)acetic acid 2.
Microorganism
(cultivation method B)
Time [days] Conversion [%] ee of product [%] ee of substrate [%] E
(SP,S); (RP,R) (SP,R); (RP,S) (SP,S) (SP,R) (RP,R) (RP,S) (SP,S) (SP,R)
P. minioluteum 3 55 54 71 68 91 81 18.6 12.9
F. oxysporum 3 52 51 86 76 93 82 44.0 18.5
A. niger 3 47 37 67 50 56 34 8.7 4.2
P. purpurogenum 3 38 31 <5 <5 <5 <5 – –
A. fumigatus 3 31 30 82 75 39 27 6.5 9.1
M. circinelloides 3 30 29 <5 <5 <5 <5 – –
P. crustosum 3 25 25 17 11 7 –a 1.5 –
P. funiculosum 3 18 18 46 –a 15 –a 3.1 –
a The separation of enantiomers was not detected.
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the enantiomeric excess of the unreacted compound 1.
Enzymatic acylation of 2-hydroxy-2-(ethoxyphenylphosphinyl)
acetic acid 1 (200 mg of lipase, 0.036 mmol of substrate,
0.165 mmol of vinyl butyrate) was effective only in case of PPL.
After 4 days of biotransformation the conversion reaches 45% and
enantiomeric excess of product was 11% for (SP,S) and 43% for
(SP,R) enantiomers. For other enzymes conversion was lower than
10%. Also in this example the SP preference could be observed.
3.4. Microbial hydrolysis of 2
The compound 2 was also hydrolyzed using whole fungal cells.
Microbial hydrolysis gave the most satisfactory results. The possi-
ble explanation of this is that enzymes are protected inside the
cells against the external biocatalysis conditions [16] and against
the xenobiotic substrate, which can perform the inhibitory activity
towards particular enzymes of microbial enzymatic system, but do
not influence all enzymes that are involved in examined reaction.
Performed screening, shows that the highest hydrolytic activity
towards compound 2 is performed by P. minioluteum and
F. oxysporum. The conversion degree reached 54% after 3 days of
biotransformation and enantiomeric excesses ranged between
68% and 93%. Application of A. fumigatus and A. niger as biocatalysts
allowed obtaining compound 1 with average conversion degree
(respectively 31% and 47%) and enantioselectivity (enantiomeric
excess between 50% and 82% for product enantiomers). The best
results are bolded in Table 2. M. circinelloides, P. purpurogenum,
P. crustosum and P. funiculosum were also able to bioconvert tested
compound, but with very low enantioselectivity. In the case of
other tested strains hydrolytic activity was not observed.
B. bassiana, G. candidum, R. glutinis, R. gracilis, R. mucilaginosa, R.
toruloides, T. variabilis cultivated using method B and Penicilium sp.,
F. culmorum, P. citrinum cultivated by method A did not show
hydrolytic activity towards tested compound.
All microorganisms active towards tested compound 2 show
SP-preference. These results are in a good agreement with those
observed in previous work were all tested bacterial species also
hydrolyzed substrate 2 with SP-configuration preferentially [14]
(see Table 2).Kinetic resolution of ethyl (1-hydroxyethyl)phenylphosphinate
was performed also applying two strategies – hydrolysis of ester:
ethyl (1-butyryloxyethyl)phenylphosphinate and enzymatic sub-
strate esterification with vinyl butyrate. All tested biocatalysts
(lipases and microorganisms of bacterial and fungal origin) prefer-
entially transform substrate with S-configuration at the carbon
atom adjacent to the phosphorus, whereas the configuration of
the phosphorus atom was meaningless [17].
Also in research which consists in hydrolysis of ethyl butyry-
loxyalkane(P-phenyl)phosphinates by bacterial species and lipases,
isomers bearing an a-carbon atom with an (S)-configuration were
hydrolyzed preferentially. Also a lack of stereoselectivity towards
the phosphorus atom was observed [18,19].4. Conclusions
A systematic study on the application of wide variety of lipases
and lipolytic microorganisms for the preparation of optically active
and pure hydroxyphosphinate derivatives has been undertaken.
Hydrolysis of ester: 2-butyryloxy-2-(ethoxyphenylphosphinyl)ace
tic acid 2 appeared to be the better strategy than the acylation of
2-hydroxy-2-(ethoxyphenylphosphinyl)acetic acid 1, what is in
good agreement with literature data. Lipase from C. cylindracea,
whole cells of P. minoluteum and F. oxysporum were able to hydro-
lyze tested ester compound with satisfactory enantioselectivity. In
the case of acylation of the substrate only porcine pancreas lipase
was able to transform hydroxyphosphinate with good yield (45%)
but with average selectivity up to 43% of ee. It is noteworthy, that
all tested biocatalysts exhibit SP-preference in stereoselectivity
direction. Also in previous work about hydrolysis of 2-butyry
loxy-2-(ethoxyphenylphosphinyl)acetic acid 2 all tested bacterial
species exhibit the SP-preference [14].
However research with ethyl butyryloxy(phenyl)methane
(P-phenyl)phosphinate, ethyl butyryloxyalkane(P-phenyl)phos-
phinates and ethyl (1-hydroxyethyl)phenylphosphinate show that
isomers bearing an a-carbon atom with an (S)-configuration were
hydrolyzed preferentially [17–19]. This allowed predicting the
stereodirection of the reaction in future bioconversion of P-C com-
pounds of similar structure.
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